{"id":233850,"date":"2025-09-29T00:00:00","date_gmt":"2025-09-29T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47041090-medtech-electrophysiology-mapping-and-ablation-devices\/"},"modified":"2026-05-12T11:01:55","modified_gmt":"2026-05-12T11:01:55","slug":"47042656-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042656-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-united-states\/","title":{"rendered":"Electrophysiology Mapping and Ablation Devices &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>The US <abbr title=\"Electrophysiology\">EP<\/abbr> mapping and ablation device market will experience <span>strong growth<\/span> through 2034, driven by the rapid expansion of <abbr title=\"Atrial Fibrillation\">AF<\/abbr> ablation procedures and the coinciding uptake\u00a0of <abbr title=\"Pulsed Field Ablation\">PFA<\/abbr> devices, which enable shorter procedure times and are supported by\u00a0favorable\u00a0clinical evidence.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Electrophysiology\">EP<\/abbr> mapping and ablation devices in US from 2019 to 2034.<\/p>\n<p><strong>Rising<\/strong>\u00a0<strong><abbr title=\"Atrial Fibrillation\">AF<\/abbr> ablation procedures will continue to drive growth across several segments of the <abbr title=\"Electrophysiology\">EP<\/abbr> mapping and ablation market<\/strong><\/p>\n<p>How have <abbr title=\"Atrial Fibrillation\">AF<\/abbr> ablation procedure volumes shifted in the US, and what device approvals have supported growth?<\/p>\n<p>What are the different levels of growth seen in paroxysmal <abbr title=\"Atrial Fibrillation\">AF<\/abbr> and persistent <abbr title=\"Atrial Fibrillation\">AF<\/abbr> ablation procedure volumes?<\/p>\n<p>What are the subsequent downstream impacts of rising <abbr title=\"Atrial Fibrillation\">AF<\/abbr> ablation volumes on associated devices?<\/p>\n<p><strong>The availability of <abbr title=\"Pulsed Field Ablation\">PFA<\/abbr> devices is driving growth in the US market.<\/strong><\/p>\n<p>Which <abbr title=\"Pulsed Field Ablation\">PFA<\/abbr> catheters have been approved in the US? Which upcoming products are expected to gain approval in the US market?<\/p>\n<p>How will market share dynamics shift with recent events occurring in this space?<\/p>\n<p><strong>Recent clinical guidelines will support the adoption of cardiac ablation procedures.<\/strong><\/p>\n<p>What changes have been made in the latest clinical guidelines regarding the use of cardiac ablation for treating cardiac arrhythmias?<\/p>\n<p>How will the recent clinical guideline updates influence physicians\u2019 opinions on ablation techniques for treating cardiac arrhythmia, particularly <abbr title=\"Atrial Fibrillation\">AF<\/abbr>?<\/p>\n<p><strong>Positive clinical data will play a crucial role in driving the adoption of <\/strong><b><abbr title=\"Electrophysiology\">EP<\/abbr> mapping and ablation devices<\/b><strong>, especially for premium-priced <abbr title=\"Pulsed Field Ablation\">PFA<\/abbr> catheters.<\/strong><\/p>\n<p>Which clinical trials have been recently conducted in this market?<\/p>\n<p>What is the anticipated impact of these clinical trials on market dynamics?<\/p>\n<p>How will the adoption of premium-priced <abbr title=\"Pulsed Field Ablation\">PFA<\/abbr> catheters be affected by the outcomes of recent clinical trials?<\/p>\n","protected":false},"template":"","class_list":["post-233850","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-electrophysiology-mapping-and-ablation-devices","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233850\/revisions"}],"predecessor-version":[{"id":539779,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233850\/revisions\/539779"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=233850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}